Text Size
124 studies found for:    psoriatic arthritis | psoriatic arthritis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Psoriasis
Intervention:
2 Active, not recruiting AMG 827 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827;   Drug: Placebo
3 Unknown † TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Intensive management or Tight control;   Drug: Standard management - Control group
4 Active, not recruiting Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 20mg;   Drug: Apremilast 30mg;   Drug: Placebo + 20 mg Apremilast;   Drug: Placebo + 30 mg Apremilast
5 Completed Study of Psoriatic Arthritis
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
6 Active, not recruiting PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 20mg;   Drug: Apremilast 30mg;   Drug: Placebo + 20 mg Apremilast;   Drug: Placebo + 30 mg Apremilast
7 Active, not recruiting Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
8 Completed Phase II Study With CC-10004 in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: CC-10004
9 Completed
Has Results 		Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: etanercept
10 Active, not recruiting PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Apremilast 20mg;   Drug: Apremilast 30mg;   Drug: Placebo + 20 mg Apremilast;   Drug: Placebo + 30 mg Apremilast
11 Active, not recruiting Efficacy and Safety of Humira in Patients With Psoriatic Arthritis in Normal Medical Practice
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
12 Active, not recruiting Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
13 Not yet recruiting Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo
14 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
15 Completed Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
Condition: Psoriatic Arthritis
Intervention:
16 Completed Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
17 Completed
Has Results 		An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CNTO 1275 63 mg;   Drug: Placebo
18 Completed Rituxan With or Without Methotrexate in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Rituximab
19 Completed Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
20 Withdrawn Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years